PreveCeutical Medical Inc.
PREV
CNSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 29.89% | 6.92% | -51.49% | 43.86% | -74.03% |
| Total Depreciation and Amortization | -5.26% | 5.56% | -5.26% | 5.56% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 67.55% | 10.19% | -1.19% | -34.45% | 45.84% |
| Change in Net Operating Assets | -83.06% | 50.53% | -7.49% | -63.20% | 142.01% |
| Cash from Operations | 42.49% | 41.21% | -221.71% | -58.61% | 24.38% |
| Capital Expenditure | -400.00% | 0.00% | 83.33% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -400.00% | 0.00% | 83.33% | -- | -- |
| Total Debt Issued | 264.91% | -85.38% | 158.28% | 62.37% | -23.46% |
| Total Debt Repaid | -50.00% | 98.61% | -- | -- | -- |
| Issuance of Common Stock | -51.22% | -14.93% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 9.39% | -40.88% | 209.60% | 64.10% | -24.59% |
| Foreign Exchange rate Adjustments | -200.00% | 108.33% | -1,300.00% | 150.00% | 71.43% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 100.00% | -290.00% | 600.00% | 66.67% |